Nikole Varhegyi

722 total citations
17 papers, 414 citations indexed

About

Nikole Varhegyi is a scholar working on Surgery, Immunology and Molecular Biology. According to data from OpenAlex, Nikole Varhegyi has authored 17 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Nikole Varhegyi's work include Immunotherapy and Immune Responses (5 papers), Fibroblast Growth Factor Research (2 papers) and CAR-T cell therapy research (2 papers). Nikole Varhegyi is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Fibroblast Growth Factor Research (2 papers) and CAR-T cell therapy research (2 papers). Nikole Varhegyi collaborates with scholars based in United States. Nikole Varhegyi's co-authors include Gina R. Petroni, Nolan A. Wages, Mark E. Smolkin, Kimberly A. Chianese‐Bullock, Craig L. Slingluff, Kelly T. Smith, William W. Grosh, Elizabeth Gaughan, Donna H. Deacon and Christopher Y. Thomas and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Nikole Varhegyi

16 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nikole Varhegyi United States 12 172 147 121 108 39 17 414
Michela Ballardini Italy 11 152 0.9× 52 0.4× 159 1.3× 47 0.4× 21 0.5× 16 347
Janelle M. Fauci United States 9 204 1.2× 72 0.5× 72 0.6× 56 0.5× 10 0.3× 19 366
Michel Coibion Belgium 11 123 0.7× 34 0.2× 69 0.6× 51 0.5× 38 1.0× 26 408
Karl Verpoort Germany 7 222 1.3× 123 0.8× 17 0.1× 64 0.6× 19 0.5× 10 370
Tashanna Myers United States 11 117 0.7× 32 0.2× 124 1.0× 41 0.4× 39 1.0× 29 385
Peey‐Sei Kok Australia 14 252 1.5× 37 0.3× 90 0.7× 35 0.3× 69 1.8× 38 555
Romain Rivoirard France 11 125 0.7× 20 0.1× 51 0.4× 49 0.5× 12 0.3× 53 307
Alfonso Yubero Spain 13 486 2.8× 40 0.3× 53 0.4× 57 0.5× 63 1.6× 45 584
Melinda S. Schuurman Netherlands 11 158 0.9× 23 0.2× 123 1.0× 50 0.5× 20 0.5× 26 375

Countries citing papers authored by Nikole Varhegyi

Since Specialization
Citations

This map shows the geographic impact of Nikole Varhegyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikole Varhegyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikole Varhegyi more than expected).

Fields of papers citing papers by Nikole Varhegyi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikole Varhegyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikole Varhegyi. The network helps show where Nikole Varhegyi may publish in the future.

Co-authorship network of co-authors of Nikole Varhegyi

This figure shows the co-authorship network connecting the top 25 collaborators of Nikole Varhegyi. A scholar is included among the top collaborators of Nikole Varhegyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikole Varhegyi. Nikole Varhegyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Meneveau, Max O., et al.. (2022). Factors Associated With Cosmetic Outcomes After Treatment With a Novel Form of Breast Intraoperative Radiation Therapy. Journal of Surgical Research. 283. 514–522.
2.
Petroni, Gina R., Ileana S. Mauldin, Kimberly A. Chianese‐Bullock, et al.. (2022). Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64). Journal for ImmunoTherapy of Cancer. 10(9). e005424–e005424. 17 indexed citations
3.
Patel, Sapna P., Gina R. Petroni, Jason Roszik, et al.. (2021). Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma. Journal for ImmunoTherapy of Cancer. 9(8). e003220–e003220. 33 indexed citations
4.
Portell, Craig A., Nolan A. Wages, Brad S. Kahl, et al.. (2021). Dose Finding Study of Ibrutinib and Venetoclax in Relapsed or Refractory Mantle Cell Lymphoma. Blood Advances. 6(5). 1490–1498. 14 indexed citations
5.
Slingluff, Craig L., Gina R. Petroni, Kimberly A. Chianese‐Bullock, et al.. (2021). Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63). Journal for ImmunoTherapy of Cancer. 9(1). e000934–e000934. 13 indexed citations
6.
Duska, Linda, Jennifer Scalici, Sarah M. Temkin, et al.. (2020). Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer. Cancer. 126(22). 4948–4956. 45 indexed citations
7.
Meneveau, Max O., Gina R. Petroni, Nikole Varhegyi, et al.. (2020). Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT. Brachytherapy. 19(5). 679–684. 11 indexed citations
9.
Wages, Nolan A., A Smith, Mitchell S. Anscher, et al.. (2020). Hypofractionated Postprostatectomy Radiation Therapy for Prostate Cancer to Reduce Toxicity and Improve Patient Convenience: A Phase 1/2 Trial. International Journal of Radiation Oncology*Biology*Physics. 109(5). 1254–1262. 10 indexed citations
10.
Melssen, Marit M., Gina R. Petroni, Kimberly A. Chianese‐Bullock, et al.. (2019). A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients. Journal for ImmunoTherapy of Cancer. 7(1). 163–163. 74 indexed citations
11.
Dillon, Patrick M., Gina R. Petroni, Bethany J. Horton, et al.. (2017). A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma. Clinical Cancer Research. 23(15). 4138–4145. 65 indexed citations
12.
Wages, Nolan A. & Nikole Varhegyi. (2017). A web application for evaluating Phase I methods using a non-parametric optimal benchmark. Clinical Trials. 14(5). 553–557. 6 indexed citations
13.
Slingluff, Craig L., Gina R. Petroni, Walter C. Olson, et al.. (2015). A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites. Cancer Immunology Immunotherapy. 65(1). 25–36. 28 indexed citations
14.
Dillon, Patrick M., Gina R. Petroni, Paula M. Fracasso, et al.. (2015). A phase II study of dovitinib in patients with recurrent or metastatic adenoid cystic carcinoma (ACC).. Journal of Clinical Oncology. 33(15_suppl). e17092–e17092. 4 indexed citations
15.
Erickson, Jeanne M., Leslie Blackhall, Valentina Brashers, & Nikole Varhegyi. (2014). An Interprofessional Workshop for Students to Improve Communication and Collaboration Skills in End-of-life Care. American Journal of Hospice and Palliative Medicine®. 32(8). 876–880. 25 indexed citations
16.
Danan, Deepa, et al.. (2014). Impact of blood transfusions on patients with head and neck cancer undergoing free tissue transfer. The Laryngoscope. 125(1). 86–91. 45 indexed citations
17.
Wages, Nolan A. & Nikole Varhegyi. (2013). pocrm: An R-package for Phase I trials of combinations of agents. Computer Methods and Programs in Biomedicine. 112(1). 211–218. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026